AINAlbany International Corp.

$61.78+11% 1Y

Is the business good?

Watch

More warning than reassurance: 3 of 9 health tests passed and margins compressing.

2 to watch, 2 without data
Fundamental health (F-score)3 / 9SEC EDGAR · Dec 31, 2025

Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.

Margin direction, 3 years−20.9 ptsderived

Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Leverage (Debt/EBITDA)bottom 7% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is AIN?

Albany International Corp. earns −2.1% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

−2.1%

Return on invested capital · cost of capital 9.0% · 11 points below what the capital costs: growth destroys value

Operating margin
−2.4%

Operating margin · Consumer Cyclical median 7.6% · 12 months to Q2 2026

Share count, year on year
−5.0%

Share count, year on year · bought back, each share owns more of the company

Gross margin
21%

Gross margin

Operating margin by fiscal year
YearOperating margin
FY202018%
FY202119%
FY202217%
FY202315%
FY202411%
FY2025−3.0%
Details›
Gross margin12 months to Q2 2026
21%
Operating margin12 months to Q2 2026
−2.4%
Net margin12 months to Q2 2026
−4.2%
Free cash flow margin
4.8%
Revenue, trailing twelve months
$1.22B
Free cash flow, trailing twelve months
$59M
Net income, trailing twelve months
−$51M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
−2.1%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.